Patents Assigned to Theranor SPRL
  • Pharmaceutical compositions of antibodies for treatment of diseases caused by influenza virus
    Patent number: 9409991
    Abstract: A pharmaceutical composition for prevention or treatment of viral infections including a formulation of full antibodies or fragments of antibodies specific to at least one of the following peptide sequences of toll-like receptor type 3: FYWNVSVHRVLGFKE (Seq ID NO:1), EYAAYIIHAYKD (Seq ID NO: 2), or to peptide sequence of interferon gamma receptor beta chain: LIKYWFHTPPSIPLQIEEYL (Seq ID NO: 3), or to peptide sequence of interferon gamma receptor alpha chain: SIILPKSLISW (Seq ID NO: 4).
    Type: Grant
    Filed: June 26, 2009
    Date of Patent: August 9, 2016
    Assignee: THERANOR SPRL
    Inventors: Michel Thiry, Andrey Martyushev-Poklad
  • PHARMACEUTICAL COMPOSITIONS OF ANTIBODIES FOR DISEASES CAUSED BY VIRUSES
    Publication number: 20110177081
    Abstract: A pharmaceutical composition for prevention or treatment of viral infections including a formulation of full antibodies or fragments of antibodies specific to at least one of the following peptide sequences of toll-like receptor type 3: FYWNVSVHRVLGFKE (Seq ID NO:1), EYAAYIIHAYKD (Seq ID NO: 2), or to peptide sequence of interferon gamma receptor beta chain: LIKYWFHTPPSIPLQIEEYL (Seq ID NO: 3), or to peptide sequence of interferon gamma receptor alpha chain: SIILPKSLISW (Seq ID NO: 4).
    Type: Application
    Filed: June 26, 2009
    Publication date: July 21, 2011
    Applicant: Theranor SPRL
    Inventors: Michel Thiry, Andrey Martyushev-Poklad